Xavier Busquet Xaubet

Professor of Cellular Biology at the University of the Balearic Islands (UIB) teaching cell biology at the Faculty of Medicine and biotechnology at the Faculty of Sciences.

Xavier has worked at the University of Geneva, New York University, University of Missouri, Memorial Sloan-Kettering Cancer Center, University of Kansas Medical Center, and the Center Molecular Biology Severo Ochoa.

He is the author of 96 publications in specialized journals. He is co-founder of Laminar Pharma and co-author of 4 patents that have been licensed to companies such as Lipopharma Therapeutics/Laminar Pharma, Pharma Concept and Ability Pharma. Xavier has participated in more than 20 research projects as researcher/principal researcher. His line of research is the study and development of new drugs (bioactive lipids of design) for the treatment of cancer and Alzheimer's disease.